Clinical trials are essential to advancing healthcare and bringing new treatments to patients. However, for many participants, the experience can often feel fragmented, complex and difficult to navigate. University of Manchester spinout Mi-Trial was created to help address these challenges.
Developed from clinical and research expertise at The University of Manchester, Mi-Trial has created an innovative clinical trial companion platform designed to improve communication, engagement and trial management for both participants and study teams.
The company’s technology combines a patient-facing mobile application with a centralised management portal that helps trial teams coordinate appointments, reminders, communications and study information more effectively. By simplifying the participant journey and improving protocol adherence, Mi-Trial aims to help clinical trials operate more efficiently while improving participant experience and retention.
Improving the Clinical Trial Experience
As clinical trials become increasingly digital and decentralised, maintaining participant engagement and ensuring efficient trial delivery has become more important than ever. Mi-Trial addresses this challenge through a flexible digital platform that can be adapted for studies ranging from small academic research projects to large multi-centre commercial trials.
The platform allows participants to access study information in one place, receive reminders and updates, manage appointments and remain connected with study teams throughout the trial process.
At the same time, researchers and sponsors benefit from streamlined scheduling, improved communication and tools designed to reduce missed visits and protocol deviations.
Built from Research, Designed for Real-World Impact
Mi-Trial was founded by Professor Alex Horsley and Professor Jacky Smith and spun out from The University of Manchester with support from The University of Manchester Innovation Factory, Medicines Evaluation Unit Limited and Elaros 24/7 Limited.
The company reflects the growing importance of digital innovation within healthcare research and clinical trial delivery. With increasing demand for remote and hybrid trial models, technologies that improve accessibility and participant engagement are playing an increasingly important role in modern healthcare research.
Mi-Trial’s scalable and secure platform has been developed to support both academic and industry-led studies, providing a modern alternative to fragmented trial communication systems and bespoke application development.
Supporting the Future of Clinical Research
As healthcare systems continue to adopt digital approaches to care delivery and research participation, Mi-Trial is helping to shape a more connected and participant-focused future for clinical trials.
By combining clinical expertise, digital innovation and patient-centred design, the company is working to improve how trials are delivered while helping accelerate the development of new treatments and therapies.
Professor Alex Horsley, Chairman and Co-Founder of Mi-Trial, said:
“Good communication and keeping people engaged are such an important part of running successful clinical trials, but too often the systems in place feel disconnected and make things harder than they need to be for both participants and research teams. Mi-Trial was developed to help create a more joined-up, participant-focused experience, while also making trial delivery smoother and more effective.”
“As clinical research continues to evolve, digital platforms are going to play a much bigger role in making trial participation more accessible, flexible and scalable.”
Professor Jacky Smith, Chief Scientific Officer and Co-Founder of Mi-Trial, said:
“There is growing recognition across healthcare research that participant experience is fundamental to the success of clinical trials. Mi-Trial was created to support better communication, improve engagement and help participants feel more connected throughout the research journey.
“By combining clinical insight with digital innovation, we believe Mi-Trial has the potential to support the future of decentralised and digitally enabled clinical research across a wide range of therapeutic areas.”
To find out more about Mi-Trial, visit www.mi-trial.com
